All In Biotech

Drug Trial Radar · NCT05627648

Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Confirmatory Study For Intracordal Administration Of KP-100LI In Patients With Vocal Fold Scar

Last checked: Nov 20, 2026Latest source record: Jul 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

62

Planned (sponsor's estimate)

Start

Dec 1, 2022

Primary completion

Jul 31, 2026

Study completion Feb 28, 2027

Sponsor

Lead sponsor
Kringle Pharma, Inc.Industry
Sponsor type
Industry
First posted
Nov 25, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to confirm the efficacy and safety of KP-100LI, a intracordal formulation containing recombinant human dHGF as the active pharmaceutical ingredient, for voice function improvement therapy in patients with vocal fold scar (including vocal fold sulcus).

Conditions

  • Vocal Fold Scar

Interventions

  • KP-100LIDrug

    Intracordal injection, 20 mcg once per week, 3 weeks

  • PlaceboDrug

    Intracordal injection, once per week, 3 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement rate in Voice Handicap Index-10 (VHI-10) score at 24 weeks of the observational periodTime frame: 24 weeks

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Fujita Health University Hospital

    Toyoake, Aichi-ken, Japan

  • Fukuoka Sanno Hospital

    Fukuoka, Fukuoka, Japan

  • Kurume University Hospital

    Kurume, Fukuoka, Japan

  • University Hospital Kyoto Prefectural University of Medicine

    Kamigyō-ku, Kyoto, Japan

  • Tohoku University Hospital

    Sendai, Miyagi, Japan

  • Kawasaki Medical School Hospital

    Kurashiki, Okayama-ken, Japan

  • Nihon University Hospital

    Chiyoda-ku, Tokyo, Japan

  • Sanno Medical Center

    Minato-Ku, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.